REDUCING PATIENT RISK AND ENHANCING CARE THROUGH THE DEVELOPMENT AND IMPLEMENTATION OF A NEW CHEST PAIN PATHWAY, EXPEDITED BY AND FOR THE COVID-19 ERA
Canterbury District Health Board
Christchurch, New Zealand
Canterbury District Health Board
Christchurch, New Zealand
University of Dundee
Dundee, Scotland
Croydon University Hospital
Croydon, England
Complejo Hospitalario Universitario Nuestra Señora de Candelaria Santa Cruz de Tenerife, Spain
Musashino Red Cross Hospital
Musashino, Japan
Centre Hospitalier Universitaire of Clermont-Ferrand
Clermont-Ferrand, France
Prisma Health Greenville Memorial Hospital
ROSE Foundation
Kuala Lumpur, Malaysia
Medcan Health Management Inc.
Toronto, Canada
Kaiser Permanente Southern California
Pasedena, California, USA
British Columbia Center for Disease Control
Vancouver, Canada
Washington University School of Medicine, Barnes-Jewish Hospital, and St. Louis Children's Hospital
St. Louis, Missouri, United States
Landspitali National University Hospital of Iceland
Reykjavik, Iceland
Tongji Hospital, Tongji Medical College, and Huazhong University of Science and Technology
Hubei, Mainland China
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung, Taiwan
National Basketball Association
New York, New York, United States
Hospital Universitario Virgen de las Nieves
Granada, Spain
The Second Norman Bethune Hospital of Jilin University
Changchun, China
Ipswich Hospital, East Suffolk and North Essex NHS Foundation Trust
National Reference Center for Herpesvirus, University Hospital Center
Limoges, France
TriCore Reference Laboratories